EDWARD J. RAPP - 30 Jun 2025 Form 4 Insider Report for AbbVie Inc. (ABBV)

Role: Director
Signature: T.O. Odutayo, Attorney-in-Fact for Edward J. Rapp
Issuer symbol: ABBV
Transactions as of: 30 Jun 2025
Net transactions value: +$32,855
Form type: 4
Filing time: 02 Jul 2025, 17:00:10 UTC
Previous filing: 13 May 2025
Next filing: 14 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
RAPP EDWARD J	Director	1 N. WAUKEGAN ROAD, NORTH CHICAGO	T.O. Odutayo, Attorney-in-Fact for Edward J. Rapp	02 Jul 2025	0001171780

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABBV	Stock Equivalent Units	Award	$32,855	+177	+0.64%	$185.62	27,785	30 Jun 2025	Common Stock	177	$185.62	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2	Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.